Presentation Information
[28-17-am08]Synthesis and Evaluation of Astatine-211-labeled Fibroblast Activation Protein Inhibitor(FAPI) for Targeted alpha-therapy medicine
○Masayuki Takamatsu1, Atsushi Shimoyama1, Ayaka Aso1, Taketo Toda1, Yuichiro Kadonaga1,2, Yoshifumi Shirakami2,3, Tadashi Watabe2,3, Taku Yoshiya4, Masayoshi Mochizuki4, Kazuhiro Ooe3, Atsushi Toyoshima3, Hiromitsu Haba5, Yang Wang5, Jens Cardinale6, Frederik Lars Giesel6, Kazuko Nakashima Kaneda1,3, Koichi Fukase1,3 (1. Grad. Sch. Sci., Osaka Univ., 2. Grad. Sch. Med., Osaka Univ., 3. IRS, Osaka Univ., 4. Peptide Institute, Inc., 5. RIKEN, 6. University Hospital Düsseldorf)